Cabozantinib, a tyrosine kinase inhibitor (TKI) is used for treating several types of cancer, including renal cell carcinoma (RCC)…
Cabozantinib, a tyrosine kinase inhibitor (TKI) is used for treating several types of cancer, including renal cell carcinoma (RCC), medullary thyroid cancer (MTC), and hepatocellular carcinoma (HCC).












